Poolbeg Pharma PLC Ordinary Shares (POLB)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

5.70p

Buy

6.00p

arrow-up0.25p (+4.46%)

Prices updated at 29 May 2026, 16:29 BST

Prices minimum 15 mins delay

Prices in GBX

Poolbeg Pharma PLC is a clinical-stage biopharmaceutical company with a core focus on transforming the cancer immunotherapy field. The Company's main asset, POLB 001, has the potential to expand administration of cancer immunotherapies from centralise ...

FTSE All-Share

-0.09%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

	6.00p - 5.40p
	6.00p - 2.50p
	-
	39.49m
	-
	100,000
	1,867,775
	4.59
	1,222,860.06
	0.18
	697.20m
	GB00BKPG7Z60
	-0.01
	-

Please note that past performance is not a reliable indicator of future returns. Pre-sale Illustration.

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.